Progenics Pharmaceuticals Comments on Velan Capital’s Preliminary Proxy Statement


You May Also Like

2017 Men’s Health Month Reaches New

Washington, D.C., June 30, 2017 (GLOBE NEWSWIRE) -- After reaching millions of people through ...

Apricus Biosciences Provides Corporate Update and Third Quarter Financial Results

Strategic Focus on Growing Global Vitaros® Revenue and Achieving Profitability in 2017Apricus Granted Type ...